Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/43392| Title: | One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes | Authors: | Cao, Davide VRANCKX, Pascal Valgimigli, Marco Sartori, Samantha Angiolillo, Dominick J. Bangalore, Sripal Bhatt, Deepak L. Feng, Yihan Ge, Junbo Hermiller, James Makkar, Raj R. Neumann, Franz -Josef Saito, Shigeru Picon, Hector Toelg, Ralph Maksoud, Aziz Chehab, Bassem M. Choi, James W. Campo, Gianluca Hernandez, Jose M. de la Torre Krucoff, Mitchell W. Kunadian, Vijay Sardella, Gennaro Spirito, Alessandro Thiele, Holger Varenne, Olivier Vogel, Birgit Zhou, Yujie Windecker, Stephan Mehran, Roxana |
Issue Date: | 2024 | Publisher: | EUROPA EDITION | Source: | EuroIntervention, 20 (10) , p. e630 -e642 | Abstract: | A short dual antiplatelet therapy (DAPT) duration has been proposed for patients at high bleeding risk (HBR) undergoing drug-eluting coronary stent (DES) implantation. Whether this strategy is safe and effective after a non-ST-segment elevation acute coronary syndrome (NSTE-ACS) remains uncertain. | Keywords: | ACS/NSTE-ACS;adjunctive pharmacotherapy;bleeding;drug-eluting stent;myocardial infarction | Document URI: | http://hdl.handle.net/1942/43392 | ISSN: | 1774-024X | e-ISSN: | 1969-6213 | DOI: | 10.4244/EIJ-D-23-00658 | ISI #: | 001257469900005 | Category: | A1 | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.